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Background: Postoperative organ dysfunction in conven-
tional surgery for abdominal aortic aneurysm (AAA) is associ-
ated with a complex inflammatory reaction, with activation of
coagulation and fibrinolysis. A prospective,observational study
was performed to define the complex plasma proteomic
changes after AAA repair and to identify factor(s) that may
affect myocardial function in uncomplicated procedures.
Methods: Ten patients undergoing infrarenal AAA repair
were investigated. Eight subjects subjected to major abdominal
surgery served as controls. Hemodynamic changes were con-
tinuously monitored by using the pressure recording analytical
method technique. The time course of plasma proteins was
investigated after induction of anesthesia and at different times
after surgery (6 h, 12 h, 24 h, 36 h) by using two-dimensional
difference gel electrophoresis, matrix-assisted laser desorp-
tion/ionization-time of flight mass spectrometry, and Western
blot. The effects of plasma on the functional properties of
isolated rat ventricular myocytes were also investigated.
Results: In AAA patients alone, 18 spots were found to change
more than two-fold in expression level, spot identification re-
vealing an increased thrombin generation 6 h after surgery. At
the same time cardiac cycle efficiency significantly reduced
versus baseline (–0.5  0.9 vs. 0.18  0.3 in AAA patients, P <
0.01; 0.4  0.1 vs. 0.2  0.3 in control surgery, not significant;
P < 0.01 group  time interaction at ANOVA). Plasma obtained
6 h after AAA surgery dose-dependently inhibited contractile
function of control rat myocytes (percent shortening fell by
51% with 10% of AAA plasma and was abolished with 20% of
AAA plasma, P < 0.001 for both). The inhibitory response was
abolished by thrombin antagonism.
Conclusions: These findings show for the first time the pos-
sible role of thrombin generation within the complex activation
of inflammatory response in causing hemodynamic instability
in the early postoperative period after AAA surgery.
WITH the population steadily aging, the prevalence of
high-risk patients among adults undergoing vascular sur-
gery is increasing each year.1 The different prospective
indices for the prediction of perioperative cardiac risk in
noncardiac surgery all include abdominal aortic operation
as a major predictor of perioperative mortality and morbid-
ity.2,3 There is great interest both in understanding the
causes and in optimizing perioperative treatment strategies
in this clinical setting to minimize cardiovascular risk.
Postoperative organ dysfunction in conventional sur-
gery for aortic aneurysm is associated with a particular
biologic response strictly related to an ischemia/reper-
fusion injury.4,5 After aortic surgery, a complex inflam-
matory reaction ensues, with activation of coagulation
and fibrinolysis. In particular, the unwanted inflamma-
tory response6,7 has been reported to be associated with
perioperative organ dysfunction,4,8 whereas the exten-
sive thrombin generation9–11 is considered to be a major
contributor to thrombotic complications occurring in
the early postoperative period, including myocardial in-
farction, lower extremity and intestinal ischemia, stroke,
and venous thrombosis.12 However, the use of prota-
mine to reverse the anticoagulant effects of heparin in
patients undergoing vascular surgery has been reported
to be associated with increased pulmonary artery pres-
sure and heart rate and systemic vascular resistance and
decrease in blood pressure and cardiac output.13 The
impaired myocardial oxygen consumption and function
after protamine administration were found to be inde-
pendent of myocardial ischemia.14–16 Although prota-
mine may directly affect isolated myocyte contractile
function,16 the hypothesis that thrombin may directly
depress cardiac function might be considered. Experi-
ments performed to investigate the effects of thrombin
on the functional properties of cardiomyocytes yielded
conflicting results, showing either an increase17,18 or a
reduction in myocyte contraction strength.19,20
The current study was therefore performed to investigate
(1) serial changes in plasma proteome after abdominal
aortic aneurysm repair, (2) the effects of plasma obtained
from operated patients on rat myocyte contractility, and (3)
the factor responsible for cryptic hemodynamic alterations.
Materials and Methods
Subjects Investigated
Two groups of patients scheduled for elective aortic
reconstructive surgery for infrarenal abdominal aortic
aneurysm repair (AAA, n  10) or nonlaparoscopic elec-
tive abdominal surgery (gastrectomy, 1; intestinal resec-
tion, 1; nephrectomy, 6) (AS, n  8), were investigated
(table 1). The preoperative examination included phys-
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ical examination, standard 12-lead electrocardiography,
and dobutamine stress echocardiography. Exclusion cri-
teria were diabetes, evidence of peripheral vascular dis-
ease, recent history of myocardial infarction, intestinal
chronic inflammatory disease, widespread cancer, left
ventricular ejection fraction less than 40%, symptomatic
congestive heart failure, significant segmental wall mo-
tion abnormalities before dobutamine stress echocardi-
ography, new wall motion abnormalities detected on
dobutamine stress echocardiography, and inability to
understand informed consent.
Experimental protocols were approved by the institu-
tional review board. All the patients gave their informed
written consent to participate in the study.
Experimental Protocol
Infrarenal AAA repair was performed by using standard
surgical technique; the details of surgical and anesthetic
procedure and of intraoperative monitoring have been
previously presented.5 Aortic clamping lasted 30 to 60
min. AAA patients received 30 IU/kg of heparin intrave-
nously before clamping, and low molecular weight hep-
arin (nadroparin 4,000 IU sc) for 15 days from the first
postoperative day. AS patients received low–molecular
weight heparin (nadroparin 2,500 IUsc) before surgery
and 2,500–4,000 U, depending on weight, from the first
postoperative day for 1 week. No subject received pro-
tamine. Transthoracic echocardiography was repeated at
the end and at 24 and 48 h after the end of surgery.
Venous blood samples (3 ml) were collected in K2EDTA-
containing tubes after induction of anesthesia (baseline)
and at 6, 12, 24, and 36 h after surgery as previously
reported.5 Blood was centrifuged at 4°C, 1,000g for 10
min, and the isolated plasma samples were stored at
80°C until use.
Hemodynamic Monitoring
Hemodynamic changes were continuously monitored
by using a system based on online, real-time, digital
processing of intraarterial radial pressure waveform anal-
ysis. A standard arterial catheter was inserted in the
radial artery. Pressure signals were obtained at 1,000 Hz
by means of an analogic-digital DAQ Card-700 (National
Instruments Corp., Austin, TX) and recorded on a per-
sonal computer. The Pressure Recording Analytical
Method technique, based on analysis of the peripheral
artery waveform morphology, has been described else-
where.21,22 Pressure Recording Analytical Method is
based on a software (Mostcare; Vytek, Padova, Italy) that
analyzes the pressure signal obtained via the analogic
card by means of a routine that identifies the character-
istic points of the pressure wave during each beat (dia-
stolic, systolic, dicrotic, and resonant pressure points
during the systolic and end-diastolic phase). The mor-
phologic analysis of the beat allows determination of the
stroke volume that, multiplied by cardiac frequency,
provides the cardiac output value. During spontaneous
circulation, Pressure Recording Analytical Method re-
sults are based on the simultaneous evaluation of the
pulsatile and continuous components of cardiac output
flow, as expressed by the arterial waveform.21,22
Proteomic Studies
Two-dimensional Electrophoresis. An aliquot of
6.25 l of human plasma was mixed with 10 l of a
solution containing Sodium Dodecyl Sulfate (10% w/v)
and dithioerythritol (2.3% w/v). The sample was heated
to 95°C for 5 min and then diluted to 500 l with a
solution containing urea (8 M), 3-cholamidopropyl dim-
ethylammonium-1-propane sulfonate (4% w/v), Tris (40
mM), dithioerythritol (65 mM), and a trace of bromophe-
nol blue.23 Two-dimensional electrophoresis was per-
formed by using the Immobiline polyacrylamide system.
Briefly, 60 g of the final diluted plasma sample for the
analytical gels and 500 g for the preparative gels were
loaded onto a commercial nonlinear immobilized pH
gradient from pH 3 to pH 10 of 18 cm length (Amersham
Biosciences, Uppsala, Sweden). Isoelectric focusing was
carried out on the Ettan Immobilized pH gradient phor
system (Amersham Biosciences). Immobilized pH gradi-
ent strips were rehydrated in 350 l of lysis buffer and
0.2% (v/v) carrier ampholyte for 1 h at 0 V and for 8 h at
30 V at 16°C. The strips were focused according to the
following electrical conditions at 16°C: 200 V for 1 h,
from 300 to 3,500 V in 30 min, 3,500 V for 3 h, from
3,500 to 8,000 V in 30 min, and 8,000 V until a total of
80,000 V per h was reached. After isoelectric focusing
separation, the strips were equilibrated with 10 ml of a
solution containing 50 mM Tris-HCl pH 6.8, 6 M urea, 30%
(v/v) glycerol, 2% (w/v) Sodium Dodecyl Sulfate, and 2%
(w/v) dithioerythritol for 12 min and with 10 ml of a
solution containing 50 mM Tris-HCl pH 6.8, 6 M urea, 30%
Table 1. Clinical Characteristics and Operative Details of
Subjects Investigated
Clinical Characteristics AAA AS P Value
Gender, men/women 6/4 6/2
Age, yrs 68  6 66  7 NS
Weight, kg 72  8 79  11 NS
Height, cm 170  5 172  5 NS
Systolic blood pressure, mmHg 128  9 119  14 NS
Diastolic blood pressure, mmHg 78  10 74  9 NS
Heart rate, beats/min 71  10 75  5 NS
Smokers, n 6 4
Creatinine, mg/dl 1.03  0.3 0.9  0.1 NS
Creatinine clearance, ml/min 74  14 73  21 NS
Ejection fraction, % 56  6 57  4 NS
Cardiac mass, g/m2 119  33 115  23 NS
Operative details
Intraoperative blood losses, ml 480  200 310  160 NS
Fluids administered, ml · kg1· h1 11.5  3 10.1  2 NS
Colloids/crystalloid ratio 0.39  0.20 0.29  0.17 NS
Cross-clamping time, min 53  17 —
Duration of surgery, min 240  60 190  80 NS
Data are presented as mean  SD.
AAA  abdominal aortic aneurysm repair; AS  abdominal surgery; NS  not
significant.
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(v/v) glycerol, 2% (w/v) Sodium Dodecyl Sulfate, 2.5%
(w/v) iodoacetamide, and a trace of bromophenol blue
for 5 min. Immobilized pH gradient strips were then
placed on 12% SDS-PAGE gels (18 cm  20 cm  1.5
mm) and overlaid with a solution of 0.5% (w/v) agarose.
The second-dimensional SDS-PAGE was carried out at 40
mA constant current at 10°C until the dye front reached
the bottom of the gel. Analytical gels were stained with
ammoniacal silver nitrate as previously described.24 The
mass spectrometry–preparative gels were stained ac-
cording to a silver staining protocol compatible with
mass spectrometry.25
Image Acquisition and Data Analysis. The stained
gels were scanned using a 300S laser densitometer
(4,000–65,000 pixels, 12 bits/pixel; Molecular Dynam-
ics, Sunnyvale, CA). Image analysis used ImageMaster 2D
Platinum 6.0 software (GE Healthcare, Little Chalfont,
United Kingdom). Image spots were detected, matched,
and then manually edited. Gel images of a plasma sample
drawn from the basal time (baseline) were used as ref-
erence. Each spot intensity volume was processed by
background subtraction and total spot volume normal-
ization. Relative spot volumes (%V) (V  integration of
optical density over the spot area; %V  V single spot/V
total spots) were used for quantitative analysis to de-
crease experimental errors. The % volume of the base-
line was taken as 1.00 when the comparison was made
between groups with the use of the software.
The threshold for considering a spot “of interest” was
set at a twofold change. This quantitative difference was
selected by considering the recognized detection error
range in the reproducibility of two-dimensional electro-
phoresis gels. Only the significantly different spots were
selected for mass spectrometry analysis.
Protein Identification by Peptide Mass Finger-
printing. The spots of interest were manually excised
from gels and destained in 30 mM potassium ferricya-
nide/100 mM sodium thiosulfate/H2O solution (1:1:2, by
volume). Gel pieces were then washed six times with
deionized water, equilibrated with 200 mM ammonium
bicarbonate for 20 min, washed with deionized water,
dehydrated twice with acetonitrile for 20 min, and in-gel
digested with trypsin (Trypsin Gold, mass spectrometry
grade; Promega, Milan, Italy) 10 g/ml at 30°C for 16 h
in 50 mM ammonium bicarbonate buffer pH 8.0, according
to the manufacturer’s protocol. Peptides were extracted
from the gel with 50% acetonitrile/5% trifluoroacetic acid
(two steps, 20 min at room temperature each), dried, re-
suspended with 0.1% trifluoroacetic acid in 50% acetoni-
trile, mixed with matrix (C18 cyano-4-hydroxycinnamic
acid), and analyzed by using Voyager-DE0 matrix-assisted
laser desorption/ionization-time of flight mass spectrome-
ter (Applied Biosystems, Foster City, CA).§§
Western Blot Analysis. Plasma protein samples (40
g), obtained at different times after AAA and AS from all
patients (before and 6 h, 12 h, 24 h, and 36 h after
surgery), were separated by 12% SDS-PAGE and trans-
ferred onto polyvinylidene fluoride membrane (Milli-
pore, Billerica, MA).Western blot was performed by us-
ing a polyclonal antibody against Thrombin (sc-59717;
Santa Cruz Biotechnology, Santa Cruz, CA) and peroxi-
dase-conjugated secondary antibody. The reaction was
detected by chemioluminescence with an ECL kit (Am-
ersham Bioscience). The amount of each band was quan-
tified with a densitometer software (Quantity One; Bio-
Rad, Hercules, CA) and normalized by using the total
protein amount detected by Ponceau red solution (Pon-
ceau S solution; Sigma-Aldrich, St. Louis, MO). Data are
shown as mean  SD of each normalized intensity of
band obtained from all patients studied at different times
after AAA and AS. A two-tailed Student t test was per-
formed by using ORIGIN 6.0 software (Microcal,
Northampton, MA) to determine whether the relative
change was statistically significant.
Rat Myocyte Isolation and Contractile Function Studies
The effects of plasma obtained at different times on
myocyte contractile function was investigated by using
cardiomyocytes isolated from rat hearts. The investiga-
tion complied with the Guide for the Care and Use of
Laboratory Animals published by the US National Insti-
tutes of Health (NIH Publication No. 85–23, revised
1985). Cardiomyocytes were isolated from adult male
Wistar rats weighing 180–230 g by the enzymatic
method, as previously reported.26 Nonmyocytes ac-
counted for less than 2% of the cells.
Cardiomyocyte systolic performance was examined by
using an IonOptix MyoCam system (IonOptix, Milton,
MA). Briefly, after 2 h of stabilization, isolated myocytes
were placed in a Warner chamber mounted on the stage
of an inverted microscope (IX-50; Olympus, Center Val-
ley, PA) and superfused (1 ml/min at 36°C) with a buffer
containing the following (in mM): 131 NaCl, 4 KCl, 1
CaCl2, 1 MgCl2, 10 glucose, 10 HEPES, at pH 7.4. The
myocyte being studied was displayed on the computer
monitor with an IonOptix MyoCam camera (IonOptix),
which rapidly scans the image area every 8.3 ms so that
the amplitude and velocity of shortening/relengthening
are recorded with a good level of accuracy. Edge-detec-
tion software (IonOptix) was used to measure cell length
during shortening and relengthening. Parameters com-
puted from the digitized contraction profiles included
percent shortening, maximal velocity of shortening, and
maximal velocity of relengthening. Cells were field-stim-
ulated with suprathreshold voltage and at a frequency of
0.5 Hz. A minimum of 15 cells from each isolation was
studied (at least 60 cells/group).
The functional effects of plasma (5%, 10%, and 20%)
obtained in all patients at baseline and at 30 min and 6,
§§ Swiss Prot. Available at: http://www.expasy.org./sprot; accessed May 12,
2009.
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12, 24, and 36 h after declamping (for AAA surgery) or
after the end of surgery (for AS surgery) on myocytes
preincubated (5 min) with buffer, heparin (0.5 U/ml), or
melagatran (0.5 mol/l), a direct, competitive, revers-
ible, and noncovalent thrombin inhibitor that does not
require endogenous cofactors,27 were studied.
Statistical Analysis
Continuous variables are presented as means SD and
compared with Student t test. Categorical variables were
expressed as counts and percentages, and Fischer exact
test was used for comparison. Hemodynamic changes
and responses of plasma proteins were assessed with
Table 2. Perioperative Hemodynamic Changes in Two Groups of Subjects Investigated
AS AAA
ANOVA
(Group 
Time)Bas 6 h 12 h 18 h 24 h Bas 6 h 12 h 18 h 24 h
SBP,
mmHg
62  9 52  8 49  9 51  6 47  8 57  16 55  17 53  14 44  9.1 48  8.3 NS
DBP,
mmHg
126  8 107  16 101  7 106  15 107  12 134  29 113  18 89  16 106  12 109  10 NS
DicBP,
mmHg
96  16 68  17 58  11 62  6 57  13 84  18 74  13 66  12 63  11 66  8 NS
HR,
bpm
70  8 67  10 69  8 68  6 65  5 65  11 71  8 76  9 70  12 71  8 NS
SVR,
dynes
s/cm5
1,201  67 1,004  73 997  213 1,636  347 996  160 1,220  480 1,210  311 1,090  166 1,073  160 1,019  107 NS
CCE,
units
0.2  0.3 0.4  0.1 0.3  0.3 –0.1  0.4 0.4  0.2 0.18  0.3 –0.5  0.9* –0.2  0.5 0.2  0.3 0.3  0.1 0.01
CO,
l/min
4.9  1.1 5.3  1.4 4.9  0.8 4.6  0.6 5.0  0.7 5.4  1.3 5.0  1.5 4.7  0.7 4.8  1 5.2  0.8 NS
dP/dt, 103
mmHg/s
0.9  0.3 1.1  0.2 0.9  0.2 0.9  0.3 1.0  0.3 1.5  0.5 1.2  0.4 0.9  0.4* 0.9  0.2 1.0  0.2 0.01
Values are presented as mean  SD.
* P  0.01 vs. baseline (Tukey test).
AAA  abdominal aortic aneurism repair (n  10); AS  abdominal surgery (n  8); Bas  baseline; CCE  cardiac cycle efficiency; CO  cardiac output; DBP 
diastolic blood pressure; DicBP  blood pressure corresponding to dicrotic incisure; dP/dt  changes in arterial pressure vs. time; HR  heart rate; NS  not
significant; SBP  systolic blood pressure; SVR  systemic vascular resistance.
Fig. 1. Representative two-dimensional electrophoresis of plasma obtained before (baseline) and at 6 and 36 h after abdominal aortic
aneurysm surgery (AAA) (panels A, B, C) or abdominal surgery (AS) (panels D, E, F) using a pH range of 3 to 10. Spots marked by
their numbers show the location of the proteins that were altered in their expression (table 3). bas.  baseline; Mr  relative mass;
nonlinear IPG  nonlinear immobilized pH gradient.
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ANOVA for repeated measurements (group and time
as main effects, and group  time interaction) fol-
lowed by post hoc analyses (Tukey test) to compare
later points to baseline or groups to each other at
various time points.
In studies performed with isolated myocytes, re-
sponses of different variables in the two groups were
assessed with a generalized linear model where con-
trolled sources of variation included in the model were
the concentration of plasma added, the time point at
which plasma was withdrawn, and group. A further
model was fitted allowing interaction terms among time,
group, and concentration of plasma added. Post hoc
analyses were then performed to discriminate the group
and times responsible for differences. Analysis was per-
formed on an intention-to-treat basis.
All P values were two-tailed, with statistical signifi-
cance set at 0.01, and confidence intervals (CI) were
calculated at the 99% levels. All statistical analyses
were performed with the SPSS 15.0 software (SPSS,
Inc., Chicago, IL).
Results
Clinical Outcomes
Patients undergoing infrarenal AAA repair and AS, re-
spectively, were comparable in terms of demographics
and preoperative risk factors (table 1). The mean intra-
operative blood loss and duration of anesthesia were also
comparable in the two groups (table 1). The mean time
of muscle ischemia (aortic clamping) in patients under-
going AAA was 53  17 min (range 30–70 min) with no
ischemia–reperfusion in the other group.
No patients had ST-segment changes at electrocardiog-
raphy at any time during the study or received cardio-
vascular drugs or other support to cardiac function in
the perioperative observation period. No patients died in
the operating room, had to return to the operating room
within 6 days, or had a postoperative stay less than 48 h.
The time course assessment of cardiac systolic function
(left ventricular ejection fraction) at transthoracic echo-
cardiography performed before and after surgery did not
reveal any differences between groups. Likewise, nei-
ther cardiac output nor systolic and diastolic pressure
changes differed between groups (ns at ANOVA test for
all) (table 2). Conversely, ANOVA test revealed a signif-
icantly different curve for changes of both in cardiac
cycle efficiency (CCE) and maximal rate of rise in the
arterial pulse curve (dP/dt) measured in patients under-
going AAA and AS surgery (P  0.01 for both variables)
(table 2). In particular, post hoc analyses revealed a
significant reduction of CCE and dP/dt in AAA patients at
6 h and 12 h, respectively (P  0.01 vs. baseline for
both). Conversely, no significant changes were observed
in patients undergoing AS surgery.
Table 3. Identification of Analyzed Proteins
Spot - Protein Name AC Identification method Theoretical pI/Mr (kDa) ExperimentalpI/Mr (kDa) Seq Cov %
1 - Fibrinogen  chain P02675 Pl.map, MS 7.15/51.57 6.47/52.57 22%
2 - Fibrinogen  chain P02679 Pl.map 5.24/48.48 5.22/47.78
3 - Fibrinogen /–E chain P02671 Pl.map, MS 5.79/91.36 6.82/63.09 18%
4 - Complement factor B P00751 Pl.map 6.66/83.00 6.12/77.55
5 - Ceruloplasmin P00450 Pl.map 5.41/120.08 5.99/114.98
6 - Haptoglobin  chain P00738 Pl.map, MS 6.13/43.35 5.10/40.93 29%
7 - -2-macroglobin P01023 Pl.map 5.95/160.80 5.42/151.42
8 - -2-HS-glycoprotein P02765 Pl.map, MS 5.43/39.19 4.48/54.26 26%
9 - -1 antitrypsin P01009 Pl.map, MS 5.37/44.32 4.92/58.13 28%
10 - Apolipoprotein A-IV P06727 Pl.map, MS 5.18/43.40 5.12/47.03 27%
11 - Apolipoprotein A-I P02647 Pl.map, MS 5.45/28.83 5.12/22.90 24%
12 - Retinol binding protein P02753 Pl.map, MS 5.27/21.07 5.24/20.41 30%
13 - Clusterin P10909 Pl.map 5.89/50.06 5.47/40.48
14 - Transferrin P02787 Pl.map, MS 6.70/75.18 6.36/71.90 20%
15 - Serum albumin P02768 Pl.map, MS 5.85/67.24 6.12/61.73 20%
16 - -1-antichymotripsin P01011 Pl.map 5.33/47.35 4.60/56.74
17 - Thrombin P00734 Pl.map, WB 5.64/70.03 5.00/69.46
18 - Leucine rich -2-glycopr. P02750 Pl.map, MS 6.45/37.18 4.78/54.98 29%
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Proteomic Profiling of Plasma Samples in AAA
Subjects
More than 900 spots were detected in each gel, rang-
ing from 10 to 200 kDa with a pH between 3 and 10 (fig.
1). When gels corresponding to the basal time were used
as reference in bidimensional electrophoresis (2DE) gel
analysis, the densities of 100 spots were found to change
after AAA surgery. The densities of only 18 of these 100
spots changed constantly in all patients studied. These
spots were densitometrically measured and identified by
comparison with those in the SWISS-2D database plasma
map (fig. 1).
Identification of Differentially Expressed Pro-
teins. Of the 18 differentially expressed proteins, 12
were also identified by either matrix-assisted laser
desorption/ionization-time of flight mass spectrometry
(n  11) or Western blot (n  1) analysis selected on
the basis of spot relative abundance, high variation,
and resolution on preparative gels. In particular, six
protein spots with insufficient quantities were not
processed at matrix-assisted laser desorption/ioniza-
tion analysis. The locations of differentially expressed
spots were marked with numbers in representative
gels shown in figure 1. All the identified proteins
are described, and their relative amounts are reported
in table 3.
The volume of protein spot No. 10 significantly in-
creased versus baseline at 6 h, 12 h, 24 h, and 36 h (P 
0.0001 for all); protein spots Nos. 12 and 17 were
changed versus baseline at the same confidence level
(99%) after 6 h, 12 h, and 24 h; the volumes of five
protein spots (Nos. 2, 3, 4, 8, 13) changed significantly
versus baseline at 6 and 12 h.
Table 3. Continued
%V (mean  SD)
ANOVA (time) P ValueBaseline 6 h 12 h 24 h 36 h
0.31  0.10 0.63  0.27 0.86  0.10* 0.64  0.10 0.26  0.15 0.0001
0.32  0.17 0.65  0.14* 0.61  0.08* 0.30  0.08 0.34  0.07 0.0001
0.12  0.04 0.45  0.09* 0.34  0.07* 0.09  0.04 0.15  0.06 0.0001
0.03  0.02 0.44  0.07* 0.25  0.08* 0.08  0.01 0.08  0.01 0.0001
0.04  0.02 0.05  0.02 0.03  0.01 0.20  0.09* 0.64  0.01* 0.0001
0.33  0.08 0.22  0.08 0.09  0.02* 0.07  0.02* 0.06  0.02* 0.0001
0 0.01  0.001 0.01  0.008 0.70  0.08* 0.70  0.09* 0.0001
0 0.08  0.01* 0.06  0.02* 0.02  0.009 0.02  0.007 0.0001
0 0 0 0.04  0.007 0.13  0.034* 0.0001
0 0.04  0.01* 0.04  0.007* 0.06  0.009* 0.08  0.01* 0.0001
0.03  0.006 0.03  0.005 0.07  0.01 0.24  0.09* 0.6  0.07* 0.0001
0 0.02  0.006* 0.05  0.009* 0.03  0.009* 0 0.0001
0.05  0.01 0.07  0.008* 0.03  0.008* 0*e 0* 0.0001
0.06  0.01 0.06  0.01 0.199  0.04* 0.05  0.007 0.04  0.005 0.0001
0.03  0.008 0.04  0.007 0.06  0.008 0.21  0.07* 0.27  0.09* 0.0001
0 0 0 0.2  0.08* 0.7  0.1* 0.0001
0 0.008  0.01* 0.003  0.005* 0.003  0.01* 0 0.0001
0.02  0.009 0.06  0.01 0.9  0.08 0.47  0.07* 1.5  0.3* 0.000
List of differentially expressed proteins identified in plasma from 10 patients after aortic aneurysm repair: Acute Phase Proteins (spot 1–9), Transport Proteins
(10–15), Protease and Protease inhibitors (16–17), Other (18).
* P  0.01 versus baseline (Tukey test).
AC  accession number for SwissProt/TrEMBL entry; Experimental pI/Mr  values of isoelectric point and relative mass calculated with Master 2D Platinum 6.0
(GE Healthcare, Little Chalfont, United Kingdom) by using identified proteins with known parameters as references; MSmass spectrometry; Pl.map plasma map
of SWISS-PROT 2D database; Seq Cov % percentage of amino acid sequence coverage of matched peptides in the identified proteins; Theoretical pI/Mr predicted
isoelectric point and relative mass according to protein sequence; %V  relative spot volumes of patients undergoing aortic surgery (V integration of optical density
over the spot area; %V  V single spot/V total spots); WB  Western blot.
Fig. 2. (A) Representative pattern of thrombin in the plasma of
a patient operated on for abdominal aortic aneurysm repair
before (bas.  baseline) and at 6, 12, 24, and 36 h after surgery.
Images were obtained from the two-dimensional electrophore-
sis gels using a pH range of 3 to 10. (B) Representative Western
blots for thrombin performed in plasma samples obtained be-
fore (bas.  baseline) and 6, 12, 24 and 36 h after abdominal
aortic aneurysm surgery (AAA) or abdominal surgery (AS). (C)
Densitometric assay of Western blots performed in plasma
from AAA (filled circles) and AS patients (empty circles).
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Two protein spots (Nos. 1 and 14) showed a relative
volume change in expression at 12 h that was significant
at the 99% confidence level versus baseline.
A third group of protein spots were significantly
changed after 12 h. In particular, protein spot No. 6
reduced significantly at the 99% confidence level at 12 h
(P  0.008), 24 h (P  0.002), and 36 h (P  0.001),
when compared to baseline; six spots (Nos. 5, 7, 11, 15, 16,
18) changed significantly at 24 and 36 h versus baseline
(P  0.01), spot No. 9 only at 36 h (P  0.0001).
Comparative analysis revealed that AAA repair induces
a severe change in the expression level of a number of
plasma proteins. At 6 h after declamping, a contempo-
rary increase in clusterin, complement factor B, and
fibrinogen  and /-E chain occurred. The fibrinogen
-chain was significantly increased at 12 h. All isoforms
of fibrinogen and complement factor B returned to base-
line levels 24 h after surgery (fig. 1, table 3). The expression
level of transferrin showed a peak of increase after 12 h. A
delayed peak at 24–36 h was observed for ceruloplasmin.
Conversely, haptoglobin showed a progressive reduction
in plasma levels with minimum values at 36 h.
Six hours after aortic declamping, plasma proteome
analysis revealed the presence of thrombin, -2-HSglyco-
protein, and retinol-binding-protein, which were all ab-
sent at the basal time and showed peaks at 12 and 24 h.
-1-antitrypsin, -1-antichymotripsin, and -2-macro-
globulin appeared in 2DE only 24 h after reperfusion.
Apolipoprotein A-IV, not detectable at baseline, ap-
peared at 6 h and progressively increased up to 36 h. A
similar pattern was shown by the spot of isoform Apoli-
poprotein A-I, already present at baseline and slowly
increasing with a peak at 36 h.
Fig. 3. Concentration-dependent effects on control rat myo-
cyte sarcomere shortening (%) of plasma obtained 6 h after
surgery from patients undergoing abdominal aortic aneu-
rysm surgery (AAA, P < 0.005) or abdominal surgery (AS, P
value not significant).
Table 4. Effects of Human Plasma on Rat Cardiomyocyte Function
Time Buffer
AS Plasma
5% 10% 20% 20%  Heparin
Peak velocity of sarcomere shortening, /s
Baseline 12.7  0.4 12.0  0.7 12.1  0.5 12.0  0.3 12.8  2.8
30 min 12.2  1.8 12.0  1.8 11.9  1.6 11.9  1.5 11.6  1.2
6 h 13.0  1.7 11.4  2.0 11.1  2.4 10.7  2.6 12.4  1.9
12 h 13.1  1.1 11.0  0.9 10.6  0.8 10.2  1.0 12.7  2.1
24 h 12.7  1.6 12.7  1.5 12.5  1.2 12.5  1.3 11.8  0.1
36 h 11.9  0.8 11.7  0.5 12.0  0.8 11.8  0.5 11.3  2.9
Generalized linear model analysis — — — — —
Peak velocity of sarcomere relengthening, /s
Baseline 11.5  0.9 11.1  1.2 11.1  1.2 11.5  1.1 11.8  2.0
30 min 11.8  1.0 11.6  1.0 11.6  1.3 11.8  0.9 11.5  0.8
6 h 12.7  1.8 11.4  2.1 10.9  1.7 10.3  2.2 12.3  2.8
12 h 13.0  0.8 11.2  0.9 10.7  1.1 10.2  0.9 12.0  2.7
24 h 12.1  1.0 12.2  1.1 12.0  1.3 11.8  1.1 10.6  0.1
36 h 11.7  1.1 11.6  0.9 11.6  0.9 11.5  1.0 11.1  1.2
Generalized linear model analysis — — — — —
Percent shortening, %
Baseline 14.4  1.0 14.8  0.8 14.4  1.3 14.4  1.0 14.1  1.4
30 min 11.6  0.9 13.9  1.0 13.7  0.7 13.7  1.0 13.7  1.2
6 h 14.7  1.5 13.6  2.2 13.0  1.9 13.2  3.1 14.2  1.4
12 h 13.7  2.4 11.7  2.1 11.2  2.1 10.9  2.0 15.2  1.7
24 h 13.8  1.0 14.1  0.8 14.0  1.2 14.0  0.9 12.9  0.9
36 h 14.1  1.2 14.0  0.7 14.1  1.2 14.2  1.0 13.4  3.0
Generalized linear model analysis — — — — —
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Thrombin Identification. The proteomic analysis of
the plasma protein obtained from the AAA patient group
revealed that the spot corresponding to thrombin (No.
17) was detectable between 6 h and 24 h after declamp-
ing and disappeared at 36 h. This spot was identified by
comparison of the two-dimensional electrophoresis gels
of the patients studied with the corresponding spot
present in the SWISS-2D database plasma map. Probably
because of the low amount of thrombin in plasma, it was
not possible to confirm this identification by matrix-
assisted laser desorption/ionization-time of flight mass
spectrometry. Western blot analysis was then performed
to assay thrombin on the plasma of all patients investi-
gated. Densitometric analysis (fig. 2) revealed a marked
increase in thrombin 6 h after declamping (P  0.0001
vs. baseline), followed by a progressive reduction with a
return to baseline values at 36 h (fig. 2).
Proteomic Profiling of Plasma Samples in AS
Subjects
Analysis with ImageMaster 2D Software of the 2DE gels
obtained from AS patients after induction of anesthesia
(baseline) and at 6, 12, 24, and 36 h after surgery re-
vealed great differences as compared to the AAA group.
More than 900 spots were detected in each gel, ranging
from 10 to 200 kDa with a pH between 3 and 10;
however, of the 18 spots constantly changing in AAA
patients, only 6 of these spots were detectable (fig. 1).
Moreover, these six spots showed no changes in expres-
sion levels after AS surgery as compared to baseline.
Western blot analysis for thrombin also performed on
plasma samples of the AS patients (fig. 2), showed no
changes in expression level after AS surgery as compared
to baseline.
Effect of Plasma Samples on Isolated Rat Myocytes
Mechanical properties of control myocyte were signif-
icantly affected by the group of patients who gave
plasma, the time of withdrawal, and the concentration of
plasma added to myocytes. Generalized linear model
analysis indeed revealed a three-way interaction among
group, time, and concentration of plasma added to myo-
cytes for sarcomere peak velocity of shortening (P 
0.003) and relengthening (P 0.002) and percent short-
ening (P 0.0001). The interactions of group of patients
who gave plasma and time (P  0.0001 for all contrac-
tility variables) and concentration of plasma added and
time (at least P  0.006 for all contractility variables)
were also significant as the main effects of time (P 
0.0001 for all). The effect of AAA plasma on myocyte
contractility was concentration-dependent (fig. 3).
Table 4. Continued
AAA Plasma
5% 10% 20% 20%  Heparin 20%  Melagatran
12.5  2.5 12.7  2.6 12.2  2.2 12.7  1.1 12.0  0.6
11.2  1.2 11.4  0.8 11.2  1.2* 11.0  0.8 11.2  1.1
9.5  1.6 5.3  1.0*†‡§ 0*†‡§ 10.5  1.5 10.3  1.7
7.8  0.7*† 4.3  0.4*†‡§ 0*†‡§ 10.3  1.3 10.2  0.9
8.7  0.7 6.8  0.3*†‡§ 3.9  0.3*†‡§ 11.3  0.9 11.5  1.4
10.9  2.4 11.0  2.1 10.8  2.4 11.1  0.5 11.2  0.4
†‡ *†‡§ *†‡§ — —
11.7  2.0 11.6  2.1 11.9  2.2 12.7  1.1 12.1  1.1
11.2  0.9 11.4  1.0 11.3  0.9 11.0  1.1 11.5  1.2
8.7  1.8 5.3  1.0*†‡§ 0*†‡§ 10.4  1.4 10.2  1.4
7.7  1.1*† 4.4  0.5*†‡§ 0*†‡§ 10.3  1.5 10.1  1.4
8.2  0.5‡ 6.1  0.4*†‡§ 3.7  0.3*†‡§ 10.7  0.8 11.4  1.8
10.7  1.3†‡ 10.9  1.4 10.9  1.3 10.9  0.4 11.1  1.4
†‡ *†‡§ *†‡§ — —
13.8  1.2 13.9  1.4 13.9  2.2 14.0  1.3 13.4  1.8
13.6  1.1 13.6  1.1 13.6  1.1 13.2  0.7 12.9  0.8
11.2  1.8 6.3  1.2*†‡§ 0*†‡§ 13.0  1.6 12.6  1.4
9.2  0.3*† 5.3  0.5*†‡§ 0*†‡§ 11.9  1.4 11.7  1.2
9.4  1.0‡ 7.7  0.7*†‡§ 4.6  0.3*†‡§ 12.8  1.1 12.7  0.9
13.7  3.4 13.6  3.0 13.6  3.2 13.0  1.4 12.5  0.6
†‡ *†‡§ *†‡§ — —
Values are presented as mean  SD. Each experiment was performed at least in triplicate in all patients.
Generalized linear model (group  time) and post hoc analyses (Tukey test): * P  0.01 vs. baseline; † P  0.01 vs. buffer; ‡ P  0.01 vs. control (AS plasma);
§ P  0.01 vs. heparin;  P  0.01 vs. melagatran.
AAA plasma  plasma obtained from patients undergoing abdominal aortic aneurysm repair (n  10); AS plasma  plasma obtained from patients undergoing
abdominal surgery (n  8).
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Post hoc analyses revealed that myocyte response to
AAA plasma significantly differed from the response to
AS plasma and buffer (P  0.0001 for all contractility
variables). Conversely, the response to AS plasma did not
differ from the myocyte response to buffer (NS) (table
4). In particular, preincubation of isolated rat ventricular
myocytes with 20% plasma obtained at 6, 12, and 24 h
after aortic declamping resulted in a marked impairment
of myocyte contractility. The inhibitory effect was not
observed when myocytes were preincubated with
plasma obtained either before surgery or 36 h after
declamping. Likewise, plasma obtained from AS patients
did not affect control myocyte contractility.
Inhibitory effects on myocyte contractility were abol-
ished in the presence of heparin (0.5 U/ml) or melagat-
ran (0.5 mol/l) (table 4).
Discussion
The present findings indicate that increased thrombin
generation may play a role in cryptic hemodynamic
instability in patients undergoing AAA surgery. The assay
of proteomic profiling in the current study depicted
complex changes occurring only after AAA surgery, with
marked activation of thrombin and Complement factor B
6 h after aortic declamping. This observation has impor-
tant clinical implications because it indicates a time win-
dow during which the heparin dosage used in AAA
surgery may be insufficient. Large-scale thrombin activa-
tion is known to occur in patients undergoing AAA
surgery,911 and an increase in thrombin generation
markers (thrombin-antithrombin complex) was ob-
served between 1 and 24 h after declamping.12,28 This
procoagulant state makes the use of perioperative anti-
coagulation management in AAA surgery compulsory to
reduce the risk of thrombotic complications that pre-
dominantly occur in the early postoperative period, in-
cluding myocardial infarction, lower extremity and in-
testinal ischemia, stroke, and venous thrombosis.29,30 In
extreme cases, consumptive coagulopathy may also
cause postoperative bleeding.12 However, no standard-
ized heparin treatment exists,9,12,31 and the use of hep-
arin on the first postoperative day is usually avoided.
Therefore, the first clinical implication of the current
results is that failure to use heparin treatment in the early
postoperative period or at least the low heparin dose (30
IU/kg) used during surgery in the current study, may
contribute to significant thrombin activation.
According to the current findings, thrombin activation
seems also to exert functional effects independently of
thrombosis. Plasma concentrations of both pro- and an-
tiinflammatory cytokines increase within 24 h after AAA
surgery.46,3133 The release of proinflammatory cyto-
kines, which may depend on the extent of ischemia and
reperfusion (I/R),4 seems to contribute to transient or-
gan dysfunction.5,8,34,35 The early thrombin activation is
considered to participate in the reaction by inducing
cytokine release.36,37 However, our study would seems
to suggest a different interpretation. AAA plasma ob-
tained 6 h after surgery significantly inhibited the sys-
tolic functional properties of isolated control myocytes,
an effect completely abolished by thrombin antagonism.
At the same time, the significant reduction of CCE (the
ratio between hemodynamic work performed and ener-
getic expenditure),22 with unchanged indexes of cardiac
function, might indicate an increased energy expendi-
ture of the cardiovascular system to maintain homeosta-
sis. These observations suggest a direct inhibitory effect
of thrombin on myocyte contractility. In the current
study, we did not assess the effect of thrombin on con-
trol myocytes without blood components. This issue was
investigated in previous studies with conflicting results.
Thrombin (1 U/ml) was reported to induce a rapid in-
crease in contraction strength, beat frequency, and ac-
tion potential duration in both chick17 and rat18 embry-
onic or neonatal myocytes. These effects are associated
with activation of phospholipase C,17 mitogen-activated
protein kinase activity,18 and hypertrophic response.38
However, an opposite response has been observed in
adult cells, where the same thrombin concentration in-
duced a significant reduction in percent shortening as
well as in shortening and relengthening velocity.19 Al-
though the enzymatic dissociation used to isolate myo-
cytes may alter thrombin receptor structure,20 it should
be borne in mind that this dissociation was also used to
obtain neonatal cells.17,18 Moreover, our study reveals
that the effect of plasma is reversed by heparin and the
thrombin antagonist, thus suggesting the functional in-
tegrity of the thrombin receptor. On the other hand, an
important discrepancy between the responses of neona-
tal and of adult myocytes has also been reported after
angiotensin II receptor stimulation.26 The blunted activ-
ity of intracellular phosphatase in neonatal cells39 en-
hances mitogen-activated protein kinase activity, with
increased formation of factors (endothelin-1), which are
finally active on cell contractility. Conversely, the inhib-
itory effects of thrombin on adult myocytes have been
found to be related to increased sarcolemmal Na/H
exchanger activity.40,41 Three different fibrinogen chains
also increased in plasma at 6 and 12 h after aortic
declamping, and this could be associated with increased
thrombotic risk. Fibrinogen contains two sets of three
chains (, , and ) linked by disulfide bonds, and it is
essential for fibrin formation under the influence of
thrombin.42 Activated platelets bind to fibrin via the
N-terminal of the -chain and the extreme C-terminal of
the  chain. The fibrinogen  chain was also found to
decrease cardiomyocyte contractility through binding
Intercellular Adhesion Molecule-1.43 However, the abil-
ity of thrombin antagonism to reverse the effect of
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plasma seems to rule out a major role for fibrinogen. The
second potential clinical implication of our study is thus
that the enhanced thrombin generation after AAA sur-
gery may contribute to impairing left ventricular func-
tion in the early postoperative period.
The enhanced thrombin generation observed at 6 h
after declamping is then followed (at 24 and 36 h) by an
antiproteolytic response, with expression of protease
inhibitors (-1-antichymotripsin and -1 antitrypsin),
which are not present at basal time. Although apoli-
poprotein A-IV function in the atherosclerotic process is
not well characterized, apolipoprotein A-IV overexpres-
sion was shown to produce significant protection
against atherosclerosis.44,45 This protein was signifi-
cantly increased in our patients between 6 h and 36 h
after AAA surgery.
There are also limitations to the current study that
must be recognized. Although the 2DE approach is ex-
tensively used for the separation of proteins,46 many
proteins with low concentrations may not be visible for
detection in the presence of other and high-abundance
proteins.46 In addition, more than one protein may be
present in a single gel spot.46 Finally, intergel variations
may also constitute an important limitation of the tech-
nique. To overcome these ambiguities (limitations), we
used other methods to confirm changes observed in AAA
patients. In addition, our preliminary observational study
may require following further investigation to assess the
hemodynamic effects of an early thrombin inhibition
after AAA repair, although these studies may be limited
by the perioperative hemorrhagic risk. We did not inves-
tigate the relationship between quantitative measure-
ments of plasma thrombin and hemodynamic function.
This can be considered a further limitation of the current
study. The overall numbers of open procedure has been
drastically decreasing in recent years as a result of the
advent of endovascular procedures, so that the confine-
ment of our observation to open AAA surgery might be
considered a possible limitation of the study. However,
this selection allowed us to accurately measure the rec-
ognized main source of thrombin activation in open AAA
surgery, the time of ischemia. Thrombin activation in
patients undergoing endovascular aneurysm repair was
indeed found to be even greater than in conventional
surgery,12 probably as a result of the participation of less
standardizable factors such as (1) the use of endovascu-
lar tools, (2) periprocedural release of prothrombotic
substances from the aneurysmatic thrombus, (3) con-
trast media,47 and (4) blood contact with the foreign
materials.12
In conclusion, regardless of its prothrombotic proper-
ties, thrombin may contribute to determining hemody-
namic instability and organ dysfunction in the early peri-
operative period after AAA surgery.
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